Impact of COVID-19 on corneal esthesiometry.

Autor: Tochetto LB; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., de Freitas Santoro D; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., Hirai F; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., Conte DD; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., Höfling-Lima AL; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., Sousa LB; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., Bellei NCJ; Department of Medicine, Federal University of Sao Paulo, Sao Paulo, São Paulo, Brazil., De Freitas D; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., de Oliveira LA; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil laopadilha@gmail.com.
Jazyk: angličtina
Zdroj: The British journal of ophthalmology [Br J Ophthalmol] 2022 Apr; Vol. 106 (4), pp. 458-460. Date of Electronic Publication: 2021 Nov 10.
DOI: 10.1136/bjophthalmol-2021-320003
Abstrakt: Individuals with suspected COVID-19 symptoms (n=202) were tested using nasopharyngeal RT-qPCR. All individuals underwent corneal esthesiometry measurements using the Cochet-Bonnet esthesiometer during their first visit; 50 participants underwent an additional measurement at a mean interval of 32.5 (17.8) days. COVID-19 was confirmed in 101 subjects (50%) using nasopharyngeal PCR. The mean time from symptom onset to disease diagnosis and corneal esthesiometry was 4.2 (2.1) days. Mean corneal esthesiometry findings based on the positive and negative PCR status indicated no statistical difference. This study demonstrated that COVID-19 had no effect on corneal esthesiometry in individuals with acute-phase COVID-19.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze: MEDLINE